Benefits of Pioglitazone Plus Insulin For Type 2
Oct 22, 2019
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Taylor-Eugene Simmons, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences, PharmD Candidate
Pioglitazone is an agent of Thiazolidines (TZD), an oral antidiabetic class. Associated with type 2 diabetes, TZDs have the potential to benefit individuals suffering full insulin resistance syndrome and have potential benefits for secondary complications such as cardiovascular disease....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.